跳至主要内容
临床试验/ISRCTN10499680
ISRCTN10499680进行中(未招募)未知

A feasibility study evaluating the efficacy of indwelling pleural catheters plus sclerosant in persistent symptomatic pleural effusions secondary to heart failure

orth Bristol NHS Trust0 个研究点目标入组 18 人开始时间: 2021年8月12日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. The presence of a recurrent pleural effusion secondary to heart failure that has not responded to medical therapy
  • 2. Sufficient pleural fluid for IPC insertion
  • 3. Symptomatic breathlessness warranting pleural intervention
  • 4. Pleural infection excluded to satisfaction of treating physician
  • 5. Expected survival >12 weeks
  • 6. Written informed consent to trial participation

排除标准

  • 1. Age <18 years
  • 2. Known pleural malignancy
  • 3. Pregnancy, lactation or intention to become pregnant
  • 4. Absolute contraindication to IPC insertion or therapeutic aspiration of pleural fluid
  • 5. Previous attempts at ipsilateral pleurodesis
  • 6. Evidence of extensive lung entrapment on chest x-ray or CT, or significant fluid loculation on ultrasound scan, to a level which would normally be a contraindication to attempted talc pleurodesis or IPC insertion.
  • 7. Inability to give informed consent
  • 8. Patient has no access to a telephone

研究者

发起方
orth Bristol NHS Trust

相似试验